https://sputnikglobe.com/20220426/indias-drug-controller-gives-nod-to-covaxin-for-kids-aged-6-12-years-amid-surge-in-covid-cases-1095067687.html
India’s Drug Controller Gives Nod to Covaxin for Kids Aged 6-12 Years Amid Surge in COVID Cases
India’s Drug Controller Gives Nod to Covaxin for Kids Aged 6-12 Years Amid Surge in COVID Cases
Sputnik International
In the past 24 hours, India registered 2,483 fresh COVID-19 cases and 1,399 deaths. With this, the total number of cases reached 43.1 million, while the... 26.04.2022, Sputnik International
2022-04-26T12:44+0000
2022-04-26T12:44+0000
2023-02-14T12:24+0000
health
covid-19
coronavirus
vaccination
vaccinations
vaccine
vaccine
vaccine
https://cdn1.img.sputnikglobe.com/img/07e6/04/1a/1095068912_0:28:1024:604_1920x0_80_0_0_e1c9b62ec105bb3ff3d4ffec8c5958d9.jpg
Amid rising COVID cases in the country, the Drugs Controller General of India (DCGI) on Tuesday granted restricted emergency use authorisation to Bharat Biotech's vaccine -- Covaxin -- for kids aged between 6 and 12 years. The approval came following recommendations from the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO).The company has been directed to submit safety data with due analysis every 15 days for the first two months, and monthly thereafter for five months.The DGCI also approved emergency use authorisation for Biological E’s Corbevax for children in the age group 5-12 years.Apart from this, Zydus Cadila's ZycovD has also been approved for children aged above 12 years for a two-dose regimen.Federal Health Minister Mansukh Mandaviya shared the information on Twitter. In a tweet in Hindi, he said: “India’s fight against COVID has become stronger with the recent approvals”.India began administering vaccines against COVID-19 to adolescents in the age group 15-18 years on 3 January this year. Last month, children aged 12-14 years were also included in the vaccination drive.Currently, Biological E's Corbevax is being used to inoculate children against COVID-19 in the age group of 12 to 14 years, and Covaxin is being administered to children in the age group 15-18 years.
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2022
Rahul Trivedi
https://cdn1.img.sputnikglobe.com/img/07e5/05/12/1082926121_0:-1:627:627_100x100_80_0_0_d882e1a63f627c25b7a534fb8b8234d7.jpg
Rahul Trivedi
https://cdn1.img.sputnikglobe.com/img/07e5/05/12/1082926121_0:-1:627:627_100x100_80_0_0_d882e1a63f627c25b7a534fb8b8234d7.jpg
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Rahul Trivedi
https://cdn1.img.sputnikglobe.com/img/07e5/05/12/1082926121_0:-1:627:627_100x100_80_0_0_d882e1a63f627c25b7a534fb8b8234d7.jpg
health, covid-19, coronavirus, vaccination, vaccinations, vaccine, vaccine, vaccine
health, covid-19, coronavirus, vaccination, vaccinations, vaccine, vaccine, vaccine
India’s Drug Controller Gives Nod to Covaxin for Kids Aged 6-12 Years Amid Surge in COVID Cases
12:44 GMT 26.04.2022 (Updated: 12:24 GMT 14.02.2023) In the past 24 hours, India registered 2,483 fresh COVID-19 cases and 1,399 deaths. With this, the total number of cases reached 43.1 million, while the overall number of fatalities was reported to be 523,622.
Amid rising COVID cases in the country, the Drugs Controller General of India (DCGI) on Tuesday granted restricted
emergency use authorisation to Bharat Biotech's vaccine -- Covaxin -- for kids aged between 6 and 12 years.
The approval came following recommendations from the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO).
The company has been directed to submit safety data with due analysis every 15 days for the first two months, and monthly thereafter for five months.
The DGCI also approved emergency use authorisation for
Biological E’s Corbevax for children in the age group 5-12 years.
Apart from this, Zydus Cadila's ZycovD has also been approved for children aged above 12 years for a two-dose regimen.
Federal Health Minister Mansukh Mandaviya shared the information on Twitter.
In a tweet in Hindi, he said: “India’s fight against COVID has become stronger with the recent approvals”.
India began administering vaccines against COVID-19 to adolescents in the age group 15-18 years on 3 January this year. Last month, children aged 12-14 years were also included in the vaccination drive.
Currently, Biological E's Corbevax is being used to inoculate children against COVID-19 in the age group of 12 to 14 years, and Covaxin is being administered to children in the age group 15-18 years.
